hexamethonium has been researched along with Brain Disorders in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, it is not known to what extent increased glucagon secretion during hypoglycemia in mice is neurally mediated vs." | 7.68 | Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice. ( Ahren, B; Akpan, JO; Curry, DL; Gingerich, RL; Havel, PJ; Stern, JS, 1993) |
| " In addition, it is not known to what extent increased glucagon secretion during hypoglycemia in mice is neurally mediated vs." | 3.68 | Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice. ( Ahren, B; Akpan, JO; Curry, DL; Gingerich, RL; Havel, PJ; Stern, JS, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Havel, PJ | 1 |
| Akpan, JO | 1 |
| Curry, DL | 1 |
| Stern, JS | 1 |
| Gingerich, RL | 1 |
| Ahren, B | 1 |
1 other study available for hexamethonium and Brain Disorders
| Article | Year |
|---|---|
Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice.
Topics: Animals; Atropine; Autonomic Nervous System; Blood Glucose; Brain Diseases; Eating; Female; Glucagon | 1993 |